1Shapiro DA, Rwnock S, Arrington E, et al. Aripiprazole, anovel atypical antipsychotic drug with a unique and robust pharmacology [ J ]. Neuropsychopharmaco ,2003,28 : 1400-1411.
3Bowles TM, levin GM. Aripiprazole : A new atypical antipsychotic drug [ J ]. Ann pharmacother, 2003,37 : 687-694.
4Murasaki M. AD-5423 versus haloperidol in the treatment of schizophrenic patients: results of the Japan multicentle, double-blind trial [ J ]. Eur Neuropsychopharmacol, 2002,12 : 5268.
5Gunasekara NS, Spencer CM, Keating GM. Ziprasidone : a review of its use irt schizophrenia and schizoaffective disorder[ J ]. Drugs, 2002,62 :1217-1251.
7Ogasa M,kimura T, Boylan M, et al. SM-13496 in patients with acute exacerbation of schizophrenia: a two-dosc double-blind phase Ⅱ comparison with placebo [ J ]. Schizophr Res, 2003,60 ( Suppl ) : 297.
8Fleischhacker WW, Eerdekens M, Karcher k, et al. Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic[ J ]. J Chin Psychiatry, 2003,64 : 1250-1257.
6Shapiro DA, Runock S, Arrington E, et al. Aripiprazole, anovel atypical antipsyehotie drug with a unique and robust pharmacology [ J ]. Neurosychopharmaco, 2003,28 : 1400 - 1411.
7沈渔邨.精神病学[M].第5版.北京:人民卫生出版社,2009:215.
8Shapiro DA, Runock S, Arrington E, et al. Aripiprazole, anovel atypical antipsyehotic drag with a unique and robust pharmacology [J].Neurosycharmaco,2003,28 : 1400 - 1411.
